1. "Sloan Kettering Institute Faculty"
  2. "Lymphoma"
Formats
  1. Journal Article (110)
  2. Meeting Abstract (99)
  3. Conference Paper (4)
  4. Review (4)
  5. Research Letter (2)
  6. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (220)
  2. Department of Medicine (220)
  3. Hematologic Malignancies, Division of (220)
  4. Lymphoma (220)
  5. Sloan Kettering Institute Faculty (220)
  6. GSK Faculty (165)

More Groups

People
  1. Andrew Zelenetz (65)
  2. Maria Palomba (54)
  3. Marcel Van Den Brink (47)
  4. Julie Feldstein (38)
  5. Raju Chaganti (32)
  6. Andrew Intlekofer (31)

More People

Years
  1. 2023 (13)
  2. 2022 (11)
  3. 2021 (5)
  4. 2020 (9)
  5. 2019 (15)
  6. 2018 (10)

More Years

Publications
  1. Blood (71)
  2. Journal of Clinical Oncology (16)
  3. Journal of Nuclear Medicine (6)
  4. Cancer Research (5)
  5. Laboratory Investigation (5)
  6. Modern Pathology (5)

More Publications

Publishers
  1. American Society of Hematology (71)
  2. Nature Publishing Group (28)
  3. American Society of Clinical Oncology (16)
  4. American Association for Cancer Research (15)
  5. Elsevier Inc. (15)
  6. Wiley Blackwell (8)

More Publishers

Results (220)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Unique genomic alterations and microbial profiles identified in patients with gastric cancer of African, European, and Asian Ancestry: A novel path for precision oncology
    Conference Paper

    Abate, M.; Walch, H.; Arora, K.; Vanderbilt, C. M.; Fei, T.; Drebin, H.; Shimada, S.; Maio, A.; Kemel, Y.; Stadler, Z. K.; more...
    Lippincott Williams & Wilkins (2023)

    Fulltext@MSK | Save
  • Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology
    Journal Article

    Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Characterizing the relationship between cellular kinetics and response to support dosing recommendations for Cd19-targeted 19(T2)28z1xx cell therapy
    Meeting Abstract

    Li, J.; Singh, R.; Dey, A.; Sellner, L.; Liu, R.; Dash, A.; Park, J.; Palomba, M.; Mansilla-Soto, J.; Senechal, B.; more...
    Clinical Pharmacology & Therapeutics (2023)

    Fulltext@MSK | Save
  • Investigating the relationship between cytotoxic T lymphocyte mechanical output and metabolism
    Meeting Abstract

    Wong, Y. Y.; de Jesus, M.; Huse, M.; Vardhana, S.
    Biophysical Journal (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save